Depressive disorders in the elderly and dementia: An update

Area of Science:

• Gerontology
• Neuroscience
• Psychiatry

Background:

• The link between late-life depression and Alzheimer's disease (AD) is complex and clinically challenging.
• Distinguishing between depressive disorders in the elderly and AD is difficult, impacting diagnosis and treatment.
• Recent research explores the biological continuum and shared pathological pathways.

Purpose of the Study:

• To review current findings on the relationship between depressive disorders in the elderly and Alzheimer's disease (AD).
• To examine the biological underpinnings and diagnostic challenges in differentiating these conditions.
• To discuss potential therapeutic strategies and future research directions.

Main Methods:

• Review of recent scientific literature on geriatric depression and AD.
• Analysis of studies investigating biomarkers, including pro-inflammatory molecules, BDNF, and CSF Aβ42.
• Comparative analysis of clinical and biological features of elderly depression and AD patients.

Main Results:

• Elderly individuals with depression and AD patients show elevated pro-inflammatory markers and reduced BDNF compared to controls.
• Cerebrospinal fluid (CSF) levels of amyloid-beta 42 (Aβ42) can differentiate AD from depressive disorders in the elderly.
• A biological continuum may exist between a subgroup of elderly depression and AD.

Conclusions:

• Depressive disorders in the elderly and AD share biological similarities, suggesting a potential continuum.
• CSF Aβ42 is a promising biomarker for discriminating between AD and elderly depression.
• The efficacy of antidepressant treatment in mitigating AD risk requires further investigation.